Risk factors in the acquisition of extended-spectrum β-lactamase Klebsiella pneumoniae:: a case-control study in a district teaching hospital in Taiwan

被引:62
作者
Lin, MF
Huang, ML
Lai, SH
机构
[1] Hsing Chu Hsop, Dept Hlth, Dept Internal Med, Div Infect Dis, Hsinchu 300, Taiwan
[2] Hsing Chu Hsop, Dept Hlth, Nosocomial Infect Control Comm, Hsinchu 300, Taiwan
关键词
K; pneumoniae; ESBLs; risk factors; ceftazidime;
D O I
10.1053/jhin.2002.1331
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
A case-control study was performed to find the risk factors in the acquisition of extended-spectrum P-lactamase (ESBL) Klebsiella pneumoniae. From 1 May 2001 to 30 September 2001, 422 isolates of K. pneumoniae identified by the microbiological laboratory in Hsin-Chu hospital were collected, 59 of which were ESBL-producing strains. The prevalence rate was 14% (59/422). There were 43 case patients (ESBL-producing K. pneumoniae) and 86 controls (non-ESBL-producing K. pneumoniae). Tracheostomy, insertion of a Foley catheter, endotracheal tube, nasogastric tube and central venous catheter were found to be risk factors in the acquisition of K. pneumoniae with ESBLs by univariate analysis. Tracheostomy (odds ratio, 5.13; 95% Cl, 1.24-21.1; P = 0.023) and ceftazidime use (odds ratio, 13.40; 95% CI, 1.21-148.85; P = 0.035) remained as risk factors by multivariate analysis with logistic regression. Other anti-pseudomonal agents should be used as empirical therapy to treat possible Pseudomonas aeruginosa infection in order to reduce ceftazidime use and thereby decrease the prevalence of ESBL producing strains of Enterobacteriaceae. (C) 2003 The Hospital Infection Society.
引用
收藏
页码:39 / 45
页数:7
相关论文
共 35 条
[1]   INTESTINAL DECONTAMINATION FOR CONTROL OF NOSOCOMIAL MULTIRESISTANT GRAM-NEGATIVE BACILLI - STUDY OF AN OUTBREAK IN AN INTENSIVE-CARE UNIT [J].
BRUNBUISSON, C ;
LEGRAND, P ;
RAUSS, A ;
RICHARD, C ;
MONTRAVERS, F ;
BESBES, M ;
MEAKINS, JL ;
SOUSSY, CJ ;
LEMAIRE, F .
ANNALS OF INTERNAL MEDICINE, 1989, 110 (11) :873-881
[2]   CEFTAZIDIME RESISTANCE AMONG SELECTED NOSOCOMIAL GRAM-NEGATIVE BACILLI IN THE UNITED-STATES [J].
BURWEN, DR ;
BANERJEE, SN ;
GAYNES, RP .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (06) :1622-1625
[3]   A FUNCTIONAL CLASSIFICATION SCHEME FOR BETA-LACTAMASES AND ITS CORRELATION WITH MOLECULAR-STRUCTURE [J].
BUSH, K ;
JACOBY, GA ;
MEDEIROS, AA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) :1211-1233
[4]   Survey of prevalence of extended spectrum beta-lactamases among Enterobacteriaceae [J].
Chanal, C ;
Sirot, D ;
Romaszko, JP ;
Bret, L ;
Sirot, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (01) :127-132
[5]   A CASE-CONTROL STUDY OF AN OUTBREAK OF INFECTIONS CAUSED BY KLEBSIELLA-PNEUMONIAE STRAINS PRODUCING CTX-1 (TEM-3) BETA-LACTAMASE [J].
DECHAMPS, C ;
ROUBY, D ;
GUELON, D ;
SIROT, J ;
SIROT, D ;
BEYTOUT, D ;
GOURGAND, JM .
JOURNAL OF HOSPITAL INFECTION, 1991, 18 (01) :5-13
[6]   CDC DEFINITIONS FOR NOSOCOMIAL INFECTIONS, 1988 [J].
GARNER, JS ;
JARVIS, WR ;
EMORI, TG ;
HORAN, TC ;
HUGHES, JM .
AMERICAN JOURNAL OF INFECTION CONTROL, 1988, 16 (03) :128-140
[7]   National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992-April 2000, issued June 2000 [J].
Gerberding, J ;
Gaynes, R ;
Horan, T ;
Alonso-Echanove, J ;
Edwards, J ;
Emori, G ;
Fridkin, S ;
Hageman, J ;
Henderson, T ;
Lawton, R ;
Peavy, G ;
Richards, C ;
Tolson, J ;
Wages, J .
AMERICAN JOURNAL OF INFECTION CONTROL, 2000, 28 (06) :429-448
[8]   Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: Evaluation of a national postmarketing surveillance program [J].
Itokazu, GS ;
Quinn, JP ;
BellDixon, C ;
Kahan, FM ;
Weinstein, RA .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) :779-784
[9]   Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli [J].
Jacoby, GA ;
Han, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (04) :908-911
[10]   MORE EXTENDED-SPECTRUM BETA-LACTAMASES [J].
JACOBY, GA ;
MEDEIROS, AA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (09) :1697-1704